Thank you for the quick reply Milesteg!

My posts are repeatedly deleted on the other board for being frank and now I hope to watch this stock develop and feel free to post without overt censorship.

As to Nano Antibiotics, my opinion is that there is an end game with other stock and that NanoA will carryon the proverbial torch but in what shape or form is not entirely clear. I agree with previous posts here in that there's not much here as of yet... Possibly a very rewarding entry point for a longer term investor.

Just my .02

Who are the moderators here? I can't tell from my phone. Any help would be greatly appreciated.

No way that I would interpret short half life or not having reached an MTD as negative. On the contrary, this is what will make Kevetrin so appealing to use by patients and oncologists.

GO KEVETRIN!!!

Well said, and a very thorough summary of the past!


GO LEO and GO CTIX!!!

That's gory and far from where I see it. Uplisting can happen any day now (bear trap set) and in a few hours we will read the 2nd abstract of a safe drug that reactivates P53, the guardian angel gene. Dr. Shapiro is hanging his name on K because he wants to be a part of something BIG.

GO CTIX!!!

I like that!

GO CTIX!!!

Excellent find! It's dated 4/25/15 so the word is starting to get out for certain.


GO Brilacidin!!!

Thanks for all the links! Your focus is sharp as a laser!

GO BRILACIDIN!!!

I hope he doesn't PR anything but up list the following day.

GO CTIX!

Like my nuts x2

I used to think this board was at least one notch above /@h00. I made a mistake.


Shame on all of you complicit, or swinging b@shb@t today at your own will.

Shame on all of you complicit, or swinging b@shb@t today at your own will.

Its not coordinated? You get a dozen or so new posters swinging that bashbat and you think people are not aware if whats going on? Shame on you. Shame on you all.

GO CTIX!

Well said Daubersup!!! The roaches have come looking for crumbs prior to the uplist.

GO CTIX!!!

Agreed. Shaking the tree in advance of up-listing to be expected and the stop loss orders are like a nice row of dominoes to be tumbled.

GO CTIX!!!

Hopefully Dr. Shapiro also announces end to Phase I due to safety profile.

I can dream.

GO KEVETRIN!!!

Thanks for sharing that! Made my day!

"only BRI demonstrated a 99.9% reduction compared to baseline"

AWESOME!!!


GO BRILACIDIN!!!

GREAT FIND!!! Looks like ophthalmic conditions on the horizon. And as far as I'm aware, NO, they have not announced this.


GO BRILACIDIN!!!

Thank you Biodoc, very well put.

GO KEVETRIN!

Callmecrazy, those are great stats and paint a comfortable picture of TB in the U.S. But from a public health perspective we should be prepared for the coming TB tsunami that is a result of resistance development through HIV co-infection and the increasing world population living in close quarters. TB could hit large cities like NY pretty hard and will run through cities in Asia like a never ending river.


I hope it never happens but its inevitable because TB and HIV continue to spread in the developing world and TB is easily spread.

XOC, that's a very good observation but we have no idea why they pursued Brilacidin vs. the other 2. I could only imagine that B may have been safer and better tolerated. I think that the other compounds acquired from the polyheist probably have significant value but need tweaking and that takes time and money so it just makes sense that B is pushed fwd for now.

GO BRILACIDIN!!!

Perhaps pursuit of "Orphan Drug" designation.

GO CTIX!!!

Thanks XOC! Very eye opening. Brilacidin will have a global impact and make more money for multiple indications in addition to the already established ABSSI.

GO CTIX!!! GO BRILACIDIN!!!

Suhweeeeeet! PMX 30063 is Brilacidin!

TB Market Huge, not to mention a terrible disease worldwide.

GO Brilacidin!

So sorry that K wasn't available to her and for your loss.


I never forget that its the first time that researchers saw these types of tumors shrinking. I came aboard for K and its been a LONG time but I wholeheartedly believe that KEVETRIN will become a well recognized household name.


GO CTIX!!! GO KEVETRIN!!!

No. Not necessary.

Thats exactly what I pointed out earlier. Retinoblastoma and Oral Mucositis are primed for orphan designation so our 2 new physicians are are PERFECT fit!

Some people just can't see it yet.


***its starting to sound like the polyheist announcement once again and we all know that it was a brilliant move yet some feel compelled to think that these selections were done haphazardly... Oh well.

GO CTIX on the NASDAQ!

Thanks. That picture says a mouthful!

GO CTIX!!!

All I'm gonna say is retinoblastoma, head n neck cancer with oral Mucositis, and Military Officer.

There will be elections down the line but this is a SOLID start!


GO CTIX!!!

Sorry, this is more direct link that they "are closely watching" per FB page.

http://www.biocenturytv.com/currentshows2?bcpid=4179652879001&bclid=4178277878001

CTIX just shared this link on Facebook. http://www.biocenturytv.com/home

Solid work!
Thank you!
GO Brilacidin!

Well said.

GO Kevetrin, Brilacidin and Prurisol!

Anytime!

GO CTIX!!!

Perhaps they are following a 505 pathway.


Section 505 of the Act describes three types of new drug applications: (1) an application that contains full reports of investigations of safety and effectiveness (section 505(b)(1)); (2) an application that contains full reports of investigations of safety and effectiveness but where at least some of the information required for approval comes from studies not conducted by or for the applicant and for which the applicant has not obtained a right of reference (section 505(b)(2)); and (3) an application that contains information to show that the proposed product is identical in active ingredient, dosage form, strength, route of administration, labeling, quality, performance characteristics, and intended use, among other things, to a previously approved product (section 505(j)). Note that a supplement to an application is a new drug application.


http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM079345.pdf

Thanks,I was thinking the exact same thing. Could be any day now :)

Thanks for the clarification. I wonder what the control would be?

Loanranger, I comment with the utmost respect.

I just want to add that researchers and physicians/scientists often dabble in many things and sometimes those things may be or look uncomfortable from a purely financial prospective. A bit of latitude isn't too much to ask if you want the best, they must be vetted.

GO CTIX!

Drgastrova, they went from a phase Ib to a phase II, and if you read my post you would realize that they are ALSO going head to head with cytrabine.

Dr, they saved us an ENTIRE trial. They did better than good they did SUPER!

Go Kevetrin!